참고문헌
- Carthew, R. W. and E. J. Sontheimer. 2009. Origins and Mechanisms of miRNAs and siRNAs. Cell 136: 642-655. https://doi.org/10.1016/j.cell.2009.01.035
- Kim, V. N., J. Han, and M. C. Siomi. 2009. Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol. 10: 126-139. https://doi.org/10.1038/nrm2632
- Inui, M., G. Martello, and S. Piccolo. 2010. MicroRNA control of signal transduction. Nat. Rev. Mol. Cell Biol. 11: 252-263. https://doi.org/10.1038/nrn2804
- Bartel, D. P. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233. https://doi.org/10.1016/j.cell.2009.01.002
- Chen, C. Z., I. Li, H. F. Lodish, and D. P. Bartel. 2004. MicroRNAs modulate hematopoietic lineage differentiation. Science 303: 83-86. https://doi.org/10.1126/science.1091903
- Carrington, J. C. and V. Ambros. 2003. Role of microRNAs in plant and animal development. Science 301: 336-338. https://doi.org/10.1126/science.1085242
- Baltimore, D., M. P. Boldin, R. M. O'Connell, D. S. Rao, and K. D. Taganov. 2008. MicroRNAs: new regulators of immune cell development and function. Nat. Immunol. 9: 839-845. https://doi.org/10.1038/ni.f.209
- O'Connell, R. M., D. S. Rao, A. A. Chaudhuri, and D. Baltimore. 2010. Physiological and pathological roles for microRNAs in the immune system. Nat. Rev. Immunol. 10: 111-122. https://doi.org/10.1038/nri2708
- Asirvatham, A. J., C. J. Gregorie, Z. Hu, W. J. Magner, and T. B. Tomasi. 2008. MicroRNA targets in immune genes and the Dicer/Argonaute and ARE machinery components. Mol. Immunol. 45: 1995-2006. https://doi.org/10.1016/j.molimm.2007.10.035
- Mak, A., D. A. Isenberg, and C. S. Lau. 2013. Global trends, potential mechanisms and early detection of organ damage in SLE. Nat. Rev. Rheumatol. 9: 301-310.
- Rahman, A., and D. A. Isenberg. 2008. Systemic lupus erythematosus. N. Engl. J. Med. 358: 929-939. https://doi.org/10.1056/NEJMra071297
- Tsokos, G. C. 2011. Systemic lupus erythematosus. N. Engl. J. Med. 365: 2110-2121. https://doi.org/10.1056/NEJMra1100359
- Luo, X., L. M. Tsai, N. Shen, and D. Yu. 2010. Evidence for microRNA-mediated regulation in rheumatic diseases. Ann. Rheum. Dis. 69 Suppl 1: i30-36. https://doi.org/10.1136/ard.2009.117218
- Zhu, S., W. Pan, and Y. Qian. 2013. MicroRNA in immunity and autoimmunity. J. Mol. Med. (Berl). 91: 1039-1050. https://doi.org/10.1007/s00109-013-1043-z
- Miao, C. G., Y. Y. Yang, X. He, C. Huang, Y. Huang, L. Zhang, X. W. Lv, Y. Jin, and J. Li. 2013. The emerging role of microRNAs in the pathogenesis of systemic lupus erythematosus. Cell. Signal. 25: 1828-1836. https://doi.org/10.1016/j.cellsig.2013.05.006
- Gregory, R. I., K. P. Yan, G. Amuthan, T. Chendrimada, B. Doratotaj, N. Cooch, and R. Shiekhattar. 2004. The Microprocessor complex mediates the genesis of microRNAs. Nature 432: 235-240. https://doi.org/10.1038/nature03120
- Lund, E., S. Guttinger, A. Calado, J. E. Dahlberg, and U. Kutay. 2004. Nuclear export of microRNA precursors. Science 303: 95-98. https://doi.org/10.1126/science.1090599
- Bartel, D. P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297. https://doi.org/10.1016/S0092-8674(04)00045-5
- Muljo, S. A., K. M. Ansel, C. Kanellopoulou, D. M. Livingston, A. Rao, and K. Rajewsky. 2005. Aberrant T cell differentiation in the absence of Dicer. J. Exp. Med. 202: 261-269. https://doi.org/10.1084/jem.20050678
- Chong, M. M., J. P. Rasmussen, A. Y. Rundensky, and D. R. Littman. 2008. The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. J. Exp. Med. 205: 2005-2017. https://doi.org/10.1084/jem.20081219
- Cobb, B. S., T. B. Nesterova, E. Thompson, A. Hertweck, E. O'Connor, J. Godwin, C. B. Wilson, N. Brockdorff, A. G. Fisher, S. T. Smale, and M. Merkenschlager. 2005. T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer. J. Exp. Med. 201: 1367-1373. https://doi.org/10.1084/jem.20050572
- Zhou, X., L. T. Jeker, B. T. Fife, S. Zhu, M. S. Anderson, M. T. McManus, and J. A. Bluestone. 2008. Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J. Exp. Med. 205: 1983-1991. https://doi.org/10.1084/jem.20080707
- Liston, A., L. F. Lu, D. O'Carroll, A. Tarakhovsky, and A. Y. Rudensky. 2008. Dicer-dependent microRNA pathway safeguards regulatory T cell function. J. Exp. Med. 205: 1993-2004. https://doi.org/10.1084/jem.20081062
-
Fontenot, J. D., M. A. Gavin, and A. Y. Rudensky. 2003. Foxp3 programs the development and function of
$CD4^+\;CD25^+$ regulatory T cells. Nat. Immunol. 4: 330-336. https://doi.org/10.1038/ni904 - Divekar, A. A., S. Dubey, P. R. Gangalum, and R. R. Singh. 2011. Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu. J. Immunol. 186: 924-930. https://doi.org/10.4049/jimmunol.1002218
- Belver, L., V. G. de Yebenes, and A. R. Ramiro. 2010. MicroRNAs prevent the generation of autoreactive antibodies. Immunity 33: 713-722. https://doi.org/10.1016/j.immuni.2010.11.010
- Xu, S., K. Guo, Q. Zeng, J. Huo, and K. P. Lam. 2012. The RNase III enzyme Dicer is essential for germinal center B-cell formation. Blood 119: 767-776. https://doi.org/10.1182/blood-2011-05-355412
- Ademokun, A. and M. Turner. 2008. Regulation of B-cell differentiation by microRNAs and RNA-binding proteins. Biochem. Soc. Trans. 36: 1191-1193. https://doi.org/10.1042/BST0361191
- Koralov, S. B., S. A. Muljo, G. R. Galler, A. Krek, T. Chakraborty, C. Kanellopoulou, K. Jensen, B. S. Cobb, M. Merkenschlager, N. Rajewsky, and K. Rajewsky. 2008. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 132: 860-874. https://doi.org/10.1016/j.cell.2008.02.020
- Wiesen, J. L., and T. B. Tomasi. 2009. Dicer is regulated by cellular stresses and interferons. Mol. Immunol. 46: 1222-1228. https://doi.org/10.1016/j.molimm.2008.11.012
- Satoh, M., J. Y. F. Chan, A. Ceribelli, M. Vazquez del-Mercado, and E. K. Chan. 2013. Autoantibodies to Argonaute 2 (Su antigen). Adv. Exp. Med. Biol. 768: 45-59. https://doi.org/10.1007/978-1-4614-5107-5_4
- Jakymiw, A., K. Ikeda, M. J. Fritzler, W. H. Reeves, M. Satoh, and E. K. Chan. 2006. Autoimmune targeting of key components of RNA interference. Arthritis Res. Ther. 8: R87. https://doi.org/10.1186/ar1959
- Lu, J., G. Getz, E. A. Miska, E. Alvarez-Saavedra, J. Lamb, D. Peck, A. Sweet-Cordero, B. L. Ebert, R. H. Mak, A. A. Ferrando, J. R. Downing, T. Jacks, H. R. Horvitz, and T. R. Golub. 2005. MicroRNA expression profiles classify human cancers. Nature 435: 834-838. https://doi.org/10.1038/nature03702
- Wang, H., W. Peng, X. Ouyang, W. Li, and Y. Dai. 2012. Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus. Transl. Res. 160: 198-206. https://doi.org/10.1016/j.trsl.2012.04.002
- Carlsen, A. L., A. J. Schetter, C. T. Nielsen, C. Lood, S. Knudsen, A. Voss, C. C. Harris, T. Hellmark, M. Segelmark, S. Jacobsen, A. A. Bengtsson, and N. H. Heegaard. 2013. Circulating microRNA expression profiles associated with systemic lupus erythematosus. Arthritis Rheum. 65: 1324-1334. https://doi.org/10.1002/art.37890
- Tang, Y., X. Luo, H. Cui, X. Ni, M. Yuan, Y. Guo, X. Huang, H. Zhou, N. de Vries, P. P. Tak, S. Chen, and N. Shen. 2009. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum. 60: 1065-1075. https://doi.org/10.1002/art.24436
- Te, J. L., I. M. Dozmorov, J. M. Guthridge, K. L. Nguyen, J. W. Cavett, J. A. Kelly, G. R. Bruner, J. B. Harley, and J. O. Ojwang. 2010. Identification of unique microRNA signature associated with lupus nephritis. PLoS One 5: e10344. https://doi.org/10.1371/journal.pone.0010344
- Baechler, E. C., F. M. Batliwalla, G. Karypis, P. M. Gaffney, W. A. Ortmann, K. J. Espe, K. B. Shark, W. J. Grande, K. M. Hughes, V. Kapur, P. K. Gregersen, and T. W. Behrens. 2003. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. USA 100: 2610-2615. https://doi.org/10.1073/pnas.0337679100
- Bennett, L., A. K. Palucka, E. Arce, V. Cantrell, J. Borvak, J. Banchereau, and V. Pascual. 2003. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197: 711-723. https://doi.org/10.1084/jem.20021553
- Obermoser, G. and V. Pascual. 2010. The interferon-alpha signature of systemic lupus erythematosus. Lupus 19: 1012-1019. https://doi.org/10.1177/0961203310371161
- Luo, X., L. Zhang, M. Li, W. Zhang, X. Leng, F. Zhang, Y. Zhao, and X. Zeng. 2013. The role of miR-125b in T lymphocytes in the pathogenesis of systemic lupus erythematosus. Clin. Exp. Rheumatol. 31: 263-271.
- Lu, M. C., N. S. Lai, H. C. Chen, H. C. Yu, K. Y. Huang, C. H. Tung, H. B. Huang, and C. L. Yu. 2013. Decreased microRNA(miR)-145 and increased miR-224 expression in T cells from patients with systemic lupus erythematosus involved in lupus immunopathogenesis. Clin. Exp. Immunol. 171: 91-99. https://doi.org/10.1111/j.1365-2249.2012.04676.x
-
Zhao, S., Y. Wang, Y. Liang, M. Zhao, H. Long, S. Ding, H. Yin, and Q. Lu. 2011. MicroRNA-126 regulates DNA methylation in
$CD4^+$ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheum. 63: 1376-1386. https://doi.org/10.1002/art.30196 - Stagakis, E., G. Bertsias, P. Verginis, M. Nakou, M. Hatziapostolou, H. Kritikos, D. Iliopoulos, and D. T. Boumpas. 2011. Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression. Ann. Rheum. Dis. 70: 1496-1506. https://doi.org/10.1136/ard.2010.139857
-
Pan, W., S. Zhu, M. Yuan, H. Cui, L. Wang, X. Luo, J. Li, H. Zhou, Y. Tang, and N. Shen. 2010. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus
$CD4^+$ T cells by directly and indirectly targeting DNA methyltransferase 1. J. Immunol. 184: 6773-6781. https://doi.org/10.4049/jimmunol.0904060 - Zhu, X., J. Liang, F. Li, Y. Yang, L. Xiang, and J. Xu. 2011. Analysis of associations between the patterns of global DNA hypomethylation and expression of DNA methyltransferase in patients with systemic lupus erythematosus. Int. J. Dermatol. 50: 697-704. https://doi.org/10.1111/j.1365-4632.2010.04804.x
- Richardson, B., L. Scheinbart, J. Strahler, L. Gross, S. Hanash, and M. Johnson. 1990. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 33: 1665-1673. https://doi.org/10.1002/art.1780331109
-
Zhang, Y., M. Zhao, A. H. Sawalha, B. Richardson, and Q. Lu. 2013. Impaired DNA methylation and its mechanisms in
$CD4^+T$ cells of systemic lupus erythematosus. J. Autoimmun. 41: 92-99. https://doi.org/10.1016/j.jaut.2013.01.005 -
Qin, H., X. Zhu, J. Liang, J. Wu, Y. Yang, S. Wang, W. Shi, and J. Xu. 2013. MicroRNA-29b contributes to DNA hypomethylation of
$CD4^+$ T cells in systemic lupus erythematosus by indirectly targeting DNA methyltransferase 1. J. Dermatol. Sci. 69: 61-67. https://doi.org/10.1016/j.jdermsci.2012.10.011 - Dai, Y., Y. S. Huang, M. Tang, T. Y. Lv, C. X. Hu, Y. H. Tan, Z. M. Xu, and Y. B. Yin. 2007. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus 16: 939-946. https://doi.org/10.1177/0961203307084158
- Sheedy, F. J., E. Palsson-McDermott, E. J. Hennessy, C. Martin, J. J. O'Leary, Q. Ruan, D. S. Johnson, Y. Chen, and L. A. O'Neill. 2010. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat. Immunol. 11: 141-147. https://doi.org/10.1038/ni.1828
-
Ding, S., Y. Liang, M. Zhao, G. Liang, H. Long, S. Zhao, Y. Wang, H. Yin, P. Zhang, Q. Zhang, and Q. Lu. 2012. Decreased microRNA-142-3p/5p expression causes
$CD4^+$ T cell activation and B cell hyperstimulation in systemic lupus erythematosus. Arthritis Rheum. 64: 2953-2963. https://doi.org/10.1002/art.34505 - Cannons, J. L., H. Qi, K. T. Lu, M. Dutta, J. Gomez-Rodriguez, J. Cheng, E. K. Wakeland, R. N. Germain, and P. L. Schwartzberg. 2010. Optimal germinal center responses require a multistage T cell: B cell adhesion process involving integrins, SLAM-associated protein, and CD84. Immunity 32: 253-265. https://doi.org/10.1016/j.immuni.2010.01.010
- Komori, H., H. Furukawa, S. Mori, M. R. Ito, M. Terada, M. C. Zhang, N. Ishii, N. Sakuma, M. Nose, and M. Ono. 2006. A signal adaptor SLAM-associated protein regulates spontaneous autoimmunity and Fas-dependent lymphoproliferation in MRL-Faslpr lupus mice. J. Immunol. 176: 395-400. https://doi.org/10.4049/jimmunol.176.1.395
- Alcocer-Varela, J. and D. Alarcon-Segovia. 1982. Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. J. Clin. Invest. 69: 1388-1392. https://doi.org/10.1172/JCI110579
- Boyman, O. and J. Sprent. 2012. The role of interleukin-2 during homeostasis and activation of the immune system. Nat. Rev. Immunol. 12: 180-190.
- Fan, W., D. Liang, Y. Tang, B. Qu, H. Cui, X. Luo, X. Huang, S. Chen, B. W. Higgs, B. Jallal, Y. Yao, J. B. Harley, and N. Shen. 2012. Identification of microRNA-31 as a novel regulator contributing to impaired interleukin-2 production in T cells from patients with systemic lupus erythematosus. Arthritis Rheum. 64: 3715-3725. https://doi.org/10.1002/art.34596
- Xue, F., H. Li, J. Zhang, J. Lu, Y. Xia, and Q. Xia. 2013. miR-31 regulates interleukin 2 and kinase suppressor of ras 2 during T cell activation. Genes Immun. 14: 127-131. https://doi.org/10.1038/gene.2012.58
- Helms, W. S., J. L. Jeffrey, D. A. Holmes, M. B. Townsend, N. A. Clipstone, and L. Su. 2007. Modulation of NFAT-dependent gene expression by the RhoA signaling pathway in T cells. J. Leukoc. Biol. 82: 361-369. https://doi.org/10.1189/jlb.0206120
- Rouas, R., H. Fayyad-Kazan, N. El Zein, P. Lewalle, F. Rothe, A. Simion, H. Akl, M. Mourtada, M. El Rifai, A. Burny, P. Romero, P. Martiat, and B. Badran. 2009. Human natural Treg microRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression. Eur. J. Immunol. 39: 1608-1618. https://doi.org/10.1002/eji.200838509
- Zhao, X., Y. Tang, B. Qu, H. Cui, S. Wang, L. Wang, X. Luo, X. Huang, J. Li, S. Chen, and N. Shen. 2010. MicroRNA-125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus. Arthritis Rheum. 62: 3425-3435. https://doi.org/10.1002/art.27632
- Lu, M. M., J. Wang, H. F. Pan, G. M. Chen, J. Li, H. Cen, C. C. Feng, and D. Q. Ye. 2012. Increased serum RANTES in patients with systemic lupus erythematosus. Rheumatol. Int. 32: 1231-1233. https://doi.org/10.1007/s00296-010-1761-2
- Song, A., Y. F. Chen, K. Thamatrakoln, T. A. Storm, and A. M. Krensky. 1999. RFLAT-1: a new zinc finger transcription factor that activates RANTES gene expression in T lymphocytes. Immunity 10: 93-103. https://doi.org/10.1016/S1074-7613(00)80010-2
- Liu, Y., J. Dong, R. Mu, Y. Gao, X. Tan, Y. Li, Z. Li, and G. Yang. 2013. MicroRNA-30a promotes B cell hyperactivity in patients with systemic lupus erythematosus by direct interaction with Lyn. Arthritis Rheum. 65: 1603-1611. https://doi.org/10.1002/art.37912
- Liossis, S. N., E. E. Solomou, M. A. Dimopoulos, P. Panayiotidis, M. M. Mavrikakis, and P. P. Sfikakis. 2001. B-cell kinase lyn deficiency in patients with systemic lupus erythematosus. J. Investig. Med. 49: 157-165. https://doi.org/10.2310/6650.2001.34042
- Flores-Borja, F., P. S. Kabouridis, E. C. Jury, D. A. Isenberg, and R. A. Mageed. 2005. Decreased Lyn expression and translocation to lipid raft signaling domains in B lymphocytes from patients with systemic lupus erythematosus. Arthritis Rheum. 52: 3955-3965. https://doi.org/10.1002/art.21416
- Zan, H. and P. Casali. 2013. Regulation of Aicda expression and AID activity. Autoimmunity 46: 83-101. https://doi.org/10.3109/08916934.2012.749244
- Diaz, M. 2013. The role of activation-induced deaminase in lupus nephritis. Autoimmunity 46: 115-120. https://doi.org/10.3109/08916934.2012.750303
- Jiang, C., J. Foley, N. Clayton, G. Kissling, M. Jokinen, R. Herbert, and M. Diaz. 2007. Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice. J. Immunol. 178: 7422-7431. https://doi.org/10.4049/jimmunol.178.11.7422
- Dorsett, Y., K. M. McBride, M. Jankovic, A. Gazumyan, T. H. Thai, D. F. Robbiani, M. Di Virgilio, B. Reina San-Martin, G. Heidkamp, T. A. Schwickert, T. Eisenreich, K. Rajewsky, and M. C. Nussenzweig. 2008. MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity 28: 630-638. https://doi.org/10.1016/j.immuni.2008.04.002
- Teng, G., P. Hakimpour, P. Landgraf, A. Rice, T. Tuschl, R. Casellas, and F. N. Papavasiliou. 2008. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 28: 621-629. https://doi.org/10.1016/j.immuni.2008.03.015
- De Yebenes, V. G., L. Belver, D. G. Pisano, S. Gonzalez, A. Villasante, C. Croce, L. He, and A. R. Ramiro. 2008. miR-181b negatively regulates activation-induced cytidine deaminase in B cells. J. Exp. Med. 205: 2199-2206. https://doi.org/10.1084/jem.20080579
- Dai, R., Y. Zhang, D. Khan, B. Heid, D. Caudell, O. Crasta, and S. A. Ahmed. 2010. Identification of a common lupus disease-associated microRNA expression pattern in three different murine models of lupus. PLoS One 5: e14302. https://doi.org/10.1371/journal.pone.0014302
- Thai, T. H., H. C. Patterson, D. H. Pham, K. Kis-Toth, D. A. Kaminski, and G. C. Tsokos. 2013. Deletion of microRNA-155 reduces autoantibody responses and alleviates lupus-like disease in the Fas(lpr) mouse. Proc. Natl. Acad. Sci. USA 110: 20194-20199. https://doi.org/10.1073/pnas.1317632110
- Yuan, Y., S. Kasar, C. Underbayev, D. Vollenweider, E. Salerno, S. V Kotenko, and E. Raveche. 2012. Role of microRNA-15a in autoantibody production in interferon- augmented murine model of lupus. Mol. Immunol. 52: 61-70. https://doi.org/10.1016/j.molimm.2012.04.007
- Boldin, M. P., K. D. Taganov, D. S. Rao, L. Yang, J. L. Zhao, M. Kalwani, Y. Garcia-Flores, M. Luong, A. Devrekanli, J. Xu, G. Sun, J. Tay, P. S. Linsley, and D. Baltimore. 2011. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J. Exp. Med. 208: 1189-1201. https://doi.org/10.1084/jem.20101823
- Hou, J., P. Wang, L. Lin, X. Liu, F. Ma, H. An, Z. Wang, and X. Cao. 2009. MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J. Immunol. 183: 2150-2158. https://doi.org/10.4049/jimmunol.0900707
- Luo, X., W. Yang, D. Q. Ye, H. Cui, Y. Zhang, N. Hirankarn, X. Qian, Y. Tang, Y. L. Lau, N. de Vries, P. P. Tak, B. P. Tsao, and N. Shen. 2011. A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus. PLoS Genet. 7: e1002128. https://doi.org/10.1371/journal.pgen.1002128
- Karrich, J. J., L. C. Jachimowski, M. Libouban, A. Iyer, K. Brandwijk, E. W. Taanman-Kueter, M. Nagasawa, E. C. de Jong, C. H. Uittenbogaart, and B. Blom. 2013. MicroRNA-146a regulates survival and maturation of human plasmacytoid dendritic cells. Blood 122: 3001-3009. https://doi.org/10.1182/blood-2012-12-475087
- Chan, V. S., Y. J. Nie, N. Shen, S. Yan, M. Y. Mok, and C. S. Lau. 2012. Distinct roles of myeloid and plasmacytoid dendritic cells in systemic lupus erythematosus. Autoimmun. Rev. 11: 890-897. https://doi.org/10.1016/j.autrev.2012.03.004
- Charrier, E., P. Cordeiro, M. Cordeau, R. Dardari, A. Michaud, M. Harnois, N. Merindol, S. Herblot, and M. Duval. 2012. Post-transcriptional down-regulation of Toll-like receptor signaling pathway in umbilical cord blood plasmacytoid dendritic cells. Cell. Immunol. 276: 114-121. https://doi.org/10.1016/j.cellimm.2012.04.010
- Jin, O., S. Kavikondala, L. Sun, R. Fu, M. Y. Mok, A. Chan, J. Yeung, and C. S. Lau. 2008. Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression. Lupus 17: 654-662. https://doi.org/10.1177/0961203308089410
- Jin, O., S. Kavikondala, M. Y. Mok, L. Sun, J. Gu, R. Fu, A. Chan, J. Yeung, Y. Nie, and C. S. Lau. 2010. Abnormalities in circulating plasmacytoid dendritic cells in patients with systemic lupus erythematosus. Arthritis Res. Ther. 12: R137. https://doi.org/10.1186/ar3075
- Pan, Y., T. Jia, Y. Zhang, K. Zhang, R. Zhang, J. Li, and L. Wang. 2012. MS2 VLP-based delivery of microRNA-146a inhibits autoantibody production in lupus-prone mice. Int. J. Nanomedicine 7: 5957-5967.
- Garchow, B. G., O. Bartulos Encinas, Y. T. Leung, P. Y. Tsao, R. A. Eisenberg, R. Caricchio, S. Obad, A. Petri, S. Kauppinen, and M. Kiriakidou. 2011. Silencing of microRNA-21 in vivo ameliorates autoimmune splenomegaly in lupus mice. EMBO Mol. Med. 3: 605-615. https://doi.org/10.1002/emmm.201100171
- Keller, A., P. Leidinger, A. Bauer, A. Elsharawy, J. Haas, C. Backes, A. Wendschlag, N. Giese, C. Tjaden, K. Ott, J. Werner, T. Hackert, K. Ruprecht, H. Huwer, J. Huebers, G. Jacobs, P. Rosenstiel, H. Dommisch, A. Schaefer, J. Muller-Quernheim, B. Wullich, B. Keck, N. Graf, J. Reichrath, B. Vogel, A. Nebel, S. U. Jager, P. Staehler, I. Amarantos, V. Boisguerin, C. Staehler, M. Beier, M. Scheffler, M. W. Buchler, J. Wischhusen, S. F. M. Haeusler, J. Dietl, S. Hofmann, H. P. Lenhof, S. Schreiber, H. A. Katus, W. Rottbauer, B. Meder, J. D. Hoheisel, A. Franke, and E. Meese. 2011. Toward the blood-borne miRNome of human diseases. Nat. Methods 8: 841-843. https://doi.org/10.1038/nmeth.1682
- Su, X., C. Qian, Q. Zhang, J. Hou, Y. Gu, Y. Han, Y. Chen, M. Jiang, and X. Cao. 2013. miRNomes of haematopoietic stem cells and dendritic cells identify miR-30b as a regulator of Notch1. Nat. Commun. 4: 2903.
피인용 문헌
- MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantation vol.94, pp.7, 2015, https://doi.org/10.1007/s00277-015-2369-0
- Toll-like receptors: potential targets for lupus treatment vol.36, pp.12, 2014, https://doi.org/10.1038/aps.2015.91
- Epigenetics and autoimmune diseases: the X chromosome-nucleolus nexus vol.6, pp.None, 2015, https://doi.org/10.3389/fgene.2015.00022
- The role of microRNA-1246 in the regulation of B cell activation and the pathogenesis of systemic lupus erythematosus vol.7, pp.1, 2014, https://doi.org/10.1186/s13148-015-0063-7
- The Real Culprit in Systemic Lupus Erythematosus: Abnormal Epigenetic Regulation vol.16, pp.12, 2014, https://doi.org/10.3390/ijms160511013
- The role of microRNA-31 and microRNA-21 as regulatory biomarkers in the activation of T lymphocytes of Egyptian lupus patients vol.36, pp.11, 2014, https://doi.org/10.1007/s00296-016-3550-z
- Epigenetics and Systemic Lupus Erythematosus: Unmet Needs vol.50, pp.3, 2014, https://doi.org/10.1007/s12016-015-8497-4
- Critical Link Between Epigenetics and Transcription Factors in the Induction of Autoimmunity: a Comprehensive Review vol.50, pp.3, 2014, https://doi.org/10.1007/s12016-016-8534-y
- Molecular dysfunctions in acute myeloid leukemia revealed by integrated analysis of microRNA and transcription factor vol.48, pp.6, 2014, https://doi.org/10.3892/ijo.2016.3489
- The Upregulation of Genomic Imprinted DLK1-Dio3 miRNAs in Murine Lupus Is Associated with Global DNA Hypomethylation vol.11, pp.4, 2014, https://doi.org/10.1371/journal.pone.0153509
- MicroRNA-155 Mediates Augmented CD40 Expression in Bone Marrow Derived Plasmacytoid Dendritic Cells in Symptomatic Lupus-Prone NZB/W F1 Mice vol.17, pp.8, 2014, https://doi.org/10.3390/ijms17081282
- New insights into the immunopathogenesis of systemic lupus erythematosus vol.12, pp.12, 2014, https://doi.org/10.1038/nrrheum.2016.186
- Immunopathogenesis of systemic lupus erythematosus and rheumatoid arthritis: the role of aberrant expression of non‐coding RNAs in T cells vol.187, pp.3, 2014, https://doi.org/10.1111/cei.12903
- B Cell-Related Circulating MicroRNAs With the Potential Value of Biomarkers in the Differential Diagnosis, and Distinguishment Between the Disease Activity and Lupus Nephritis for Systemic Lupus Eryth vol.9, pp.None, 2014, https://doi.org/10.3389/fimmu.2018.01473
- Wolves Trapped in the NETs-The Pathogenesis of Lupus Nephritis vol.25, pp.2, 2018, https://doi.org/10.4078/jrd.2018.25.2.81
- Effects of Major Epigenetic Factors on Systemic Lupus Erythematosus vol.22, pp.5, 2014, https://doi.org/10.29252/ibj.22.5.294
- Modeling Transcriptional Rewiring in Neutrophils Through the Course of Treated Juvenile Idiopathic Arthritis vol.8, pp.None, 2014, https://doi.org/10.1038/s41598-018-26163-4
- Elevated expression of miR‐21 and miR‐155 in peripheral blood mononuclear cells as potential biomarkers for lupus nephritis vol.22, pp.3, 2014, https://doi.org/10.1111/1756-185x.13410
- MiR-5571-3p and miR-135b-5p, derived from analyses of microRNA profile sequencing, correlate with increased disease risk and activity of rheumatoid arthritis vol.38, pp.6, 2014, https://doi.org/10.1007/s10067-018-04417-w
- Circulating Exosomal microRNAs as Biomarkers of Systemic Lupus Erythematosus vol.75, pp.None, 2020, https://doi.org/10.6061/clinics/2020/e1528
- Identifying the differentially expressed microRNAs in autoimmunity: A systemic review and meta-analysis vol.53, pp.3, 2020, https://doi.org/10.1080/08916934.2019.1710135
- Systemic lupus erythematosus (SLE): emerging therapeutic targets vol.24, pp.12, 2014, https://doi.org/10.1080/14728222.2020.1832464